The Central Drugs Standard Control Organisation (CDSCO) has approved Novo Nordisks Wegovy (semaglutide 2.4 mg) for the treatment of fatty liver disease, now called MASH (Metabolic Dysfunction-Associated Steatohepatitis)
Unfortunately, human obesity is not caused by leptin deficiency
Compounded GLP-1s are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs, so provider oversight and pharmacy credentials carry more weight here
Our travel with semaglutide guide has a complete checklist for domestic and international travel
If you want to see how that dual-action approach fits into the bigger picture, read our guide to understanding how tirzepatide works
Many products on the market contain fillers, synthetic binders, or low-quality ingredients that don't serve your health